BIVI Insider Trading
Insider Ownership Percentage: 0.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
BioVie Share Price & Price History
Current Price: $1.61
Price Change: ▲ Price Increase of +0.02 (1.26%)
As of 12/4/2025 05:00 PM ET
BioVie Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/30/2023 | Cuong V Do | CEO | Buy | 1,000 | $17.80 | $17,800.00 | 6,875 |  |
| 9/5/2023 | Steve Gorlin | Director | Sell | 856 | $30.50 | $26,108.00 | 7,568 | |
| 8/22/2023 | Richard J Berman | Director | Sell | 1,080 | $35.00 | $37,800.00 | 1,678 | |
| 6/7/2023 | Richard J Berman | Director | Sell | 598 | $58.10 | $34,743.80 | 2,321 | |
| 5/22/2023 | Richard J Berman | Director | Sell | 500 | $65.00 | $32,500.00 | 2,919 | |
| 3/27/2023 | Richard J Berman | Director | Sell | 337 | $85.20 | $28,712.40 | 4,180 | |
BioVie Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/17/2025 | Prosperity Wealth Management Inc. | 143,500 | $0.27M | 0.1% | N/A | 1.903% |  |
| 11/17/2025 | Prelude Capital Management LLC | 144,762 | $0.28M | 0.0% | N/A | 1.920% | |
| 11/17/2025 | Citadel Advisors LLC | 104,531 | $0.20M | 0.0% | N/A | 1.386% | |
| 11/14/2025 | Two Sigma Investments LP | 32,505 | $62K | 0.0% | N/A | 0.431% | |
| 11/14/2025 | Squarepoint Ops LLC | 33,294 | $63K | 0.0% | N/A | 0.442% | |
| 8/14/2025 | Jane Street Group LLC | 61,742 | $57K | 0.0% | N/A | 3.319% | |
| 8/12/2025 | XTX Topco Ltd | 43,307 | $40K | 0.0% | N/A | 2.328% | |
| 5/16/2025 | NewEdge Advisors LLC | 54,100 | $53K | 0.0% | +283.7% | 0.293% | |
| 2/17/2025 | Squarepoint Ops LLC | 14,213 | $28K | 0.0% | N/A | 0.080% | |
| 2/17/2025 | Two Sigma Investments LP | 28,713 | $57K | 0.0% | N/A | 0.162% | |
| 2/17/2025 | Millennium Management LLC | 122,619 | $0.25M | 0.0% | N/A | 0.690% | |
| 2/14/2025 | Northern Trust Corp | 16,878 | $34K | 0.0% | N/A | 0.095% | |
| 2/13/2025 | NewEdge Advisors LLC | 14,100 | $28K | 0.0% | +14,000.0% | 0.079% | |
| 2/13/2025 | Bank of Montreal Can | 50,000 | $100K | 0.0% | N/A | 0.281% | |
| 2/12/2025 | Geode Capital Management LLC | 123,408 | $0.25M | 0.0% | +223.3% | 0.694% | |
| 2/7/2025 | Prosperity Wealth Management Inc. | 31,650 | $63K | 0.0% | N/A | 0.178% | |
| 1/22/2025 | Drive Wealth Management LLC | 60,000 | $0.12M | 0.0% | N/A | 0.338% | |
| 1/15/2025 | Sanders Morris Harris LLC | 40,000 | $85K | 0.0% | N/A | 0.225% | |
| 5/14/2024 | Sheaff Brock Investment Advisors LLC | 51,400 | $27K | 0.0% | +276.9% | 0.129% | |
| 5/7/2024 | CVI Holdings LLC | 599,897 | $0.32M | 0.3% | N/A | 1.503% | |
| 11/7/2023 | Jump Financial LLC | 10,000 | $34K | 0.0% | N/A | 0.027% | |
| 10/30/2023 | Summit Trail Advisors LLC | 10,100 | $34K | 0.0% | N/A | 0.027% | |
| 10/25/2023 | Crescent Grove Advisors LLC | 11,000 | $38K | 0.0% | N/A | 0.030% | |
| 10/24/2023 | Bank of New York Mellon Corp | 15,955 | $54K | 0.0% | -51.2% | 0.043% | |
| 8/29/2023 | Garde Capital Inc. | 24,163 | $0.10M | 0.0% | +40.8% | 0.066% | |
| 7/20/2023 | AJ Wealth Strategies LLC | 23,474 | $0.10M | 0.0% | +52.2% | 0.065% | |
| 7/11/2023 | FNY Investment Advisers LLC | 8,986 | $38K | 0.0% | N/A | 0.025% | |
| 5/4/2023 | Barclays PLC | 54,117 | $0.44M | 0.0% | +117.7% | 0.150% | |
| 4/28/2023 | AJ Wealth Strategies LLC | 15,428 | $0.13M | 0.0% | N/A | 0.043% | |
| 2/24/2023 | Garde Capital Inc. | 17,163 | $0.13M | 0.0% | N/A | 0.049% | |
| 2/14/2023 | 683 Capital Management LLC | 16,110 | $0.13M | 0.0% | N/A | 0.053% | |
| 2/14/2023 | swisspartners Ltd. | 294,346 | $2.29M | 2.9% | +82.8% | 0.964% | |
| 2/7/2023 | Commonwealth Equity Services LLC | 12,175 | $94K | 0.0% | N/A | 0.040% | |
| 2/1/2023 | Bank of Montreal Can | 10,000 | $78K | 0.0% | N/A | 0.033% | |
| 1/30/2023 | International Assets Investment Management LLC | 10,500 | $82K | 0.0% | N/A | 0.034% | |
| 1/10/2023 | FNY Investment Advisers LLC | 14,200 | $0.11M | 0.2% | N/A | 0.047% | |
| 11/15/2022 | Pura Vida Investments LLC | 36,617 | $91K | 0.0% | N/A | 0.120% | |
| 5/4/2022 | swisspartners Ltd. | 10,367 | $1.87M | 1.3% | -87.1% | 0.042% | |
| 2/14/2022 | Long Focus Capital Management LLC | 20,000 | $90K | 0.0% | N/A | 0.080% | |
| 11/16/2021 | swisspartners Ltd. | 80,521 | $0.54M | 0.4% | +45.0% | 0.323% | |
| 11/12/2021 | Renaissance Technologies LLC | 53,100 | $0.36M | 0.0% | +90.3% | 0.214% | |
Data available starting January 2016
BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Read More on BioVie
Volume
128,732 shs
Average Volume
65,836 shs
Market Capitalization
$12.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.53
Who are the major institutional investors of BioVie?
Which institutional investors are buying BioVie stock?
Within the last quarter, BIVI stock was purchased by institutional investors including:
- Prelude Capital Management LLC
- Prosperity Wealth Management Inc.
- Citadel Advisors LLC
- Squarepoint Ops LLC
- Two Sigma Investments LP
